AI CAPITAL INTELLIGENCE
Digitalis Ventures | Institution profile
Institution at a glance
Digitalis Ventures invests in biomedicine and health. The firm says it backs biotechnology companies using breakthrough science and technology-enabled solutions to improve access to care and health outcomes while reducing costs. Its Companion Funds focus on animal health. Enveda named Digitalis a new investor in its 2026 Series E; the $311 million figure is the total round size, not Digitalis’s disclosed check.
Source verification date: · Investment areas, public office details, and email are from the firm’s website. Enveda’s company announcement identifies Digitalis as a new investor, corroborated by the financing report. The public email is not described as an investment-submission channel. The firm has not published comparable fund returns or an individual check size for this round.
Recorded financing connections
- Enveda2026-09-23 · Series E · USD 311,000,000
These are recorded participations, not a complete portfolio or performance score.
Names follow their disclosed form. Descriptive English renderings of Chinese names are not verified legal names. Original quotations are shown in their source language.
Key facts
| Published investment areas | Biomedicine、Human-health biotechnology、Technology-enabled access to care and health outcomes、Animal health through Companion Funds |
|---|---|
| Investment approach | Invests in solutions to unmet needs, including breakthrough-science biotechnology and technology-enabled approaches that improve health outcomes and lower costs. |
| Public office | 11 Times Square, Suite 1500A, New York, NY 10036 |
Public record
- On September 23, 2026, Enveda’s official announcement named Digitalis Ventures as a new investor in its $311 million Series E. The amount is the company’s total round size; Digitalis’s individual contribution was not disclosed.
- The financing database also records Digitalis as a participant in Enveda’s September 23, 2026 Series E. The underlying report does not disclose an individual check size.
Official contact details
- Digitalis Ventures official website: Digitalis Ventures
- Public email; not identified as an investment-submission address: info@digitalisventures.com
- Public office address: 11 Times Square, Suite 1500A, New York, NY 10036
Sources
- 1. Digitalis Ventures — official profile and contact details
Investing in solutions to unmet needs in biomedicine and health.
- 2. Digitalis Ventures — human-health investment areas
We invest in biotechnology companies leveraging breakthrough science to improve human health, and in companies building novel technology-enabled solutions to improve access to care and health outcomes while reducing costs to individuals and the healthcare system.
- 3. Digitalis Ventures — animal-health investment areas
Through our Companion Funds, we invest in companies leveraging science, technology, and design to improve animal health.
- 4. Enveda — $311 million Series E announcement
Digitalis Ventures
- 5. Enveda Series E financing report — BioXconomy
The funding was led by Catalio Capital Management, with participation from new investors including Durable Capital Partners, ICONIQ, Lightspeed, Surveyor Capital (a Citadel company), accounts advised by T. Rowe Price Investment Management, Digitalis Ventures, a notable Sovereign Wealth Fund, and Alderline Group.